awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37494640-221A468E-A1B1-4911-9456-FC8E823CEBC5
Q37494640-221A468E-A1B1-4911-9456-FC8E823CEBC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37494640-221A468E-A1B1-4911-9456-FC8E823CEBC5
Application of mechanism-based CYP inhibition for predicting drug-drug interactions.
P2860
Q37494640-221A468E-A1B1-4911-9456-FC8E823CEBC5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37494640-221A468E-A1B1-4911-9456-FC8E823CEBC5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
21303bd802f73187b46d665a9d748b9656461faf
P2860
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.